BC
BMY icon

Banced Corp’s Bristol-Myers Squibb BMY Stock Holding History

Banced Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,745
Closed -$559K – 11
2018
Q4 		$559K Buy
10,745
+242
+2% +$13K 1.21% 28
2018
Q3 		$652K Sell
10,503
-1,370
-12% -$81.3K 1.11% 25
2018
Q2 		$657K Buy
11,873
+1,222
+11% +$66K 1.12% 26
2018
Q1 		$674K Buy
10,651
+240
+2% +$15.4K 1.2% 20
2017
Q4 		$638K Sell
10,411
-164
-2% -$10.3K 1.06% 26
2017
Q3 		$674K Sell
10,575
-469
-4% -$27.4K 1.17% 20
2017
Q2 		$615K Buy
11,044
+271
+3% +$14.7K 1.14% 27
2017
Q1 		$586K Buy
10,773
+134
+1% +$7.35K 1.07% 30
2016
Q4 		$622K Buy
+10,639
New +$582K 1.17% 22
2016
Q3 		– Sell
-5,884
Closed -$348K – 102
2016
Q2 		$348K Buy
5,884
+1,710
+41% +$121K 0.65% 62
2016
Q1 		$267K Sell
4,174
-1,360
-25% -$85.8K 0.47% 91
2015
Q4 		$381K Sell
5,534
-350
-6% -$23.1K 0.68% 60
2015
Q3 		$348K Sell
5,884
-1,372
-19% -$87K 0.64% 65
2015
Q2 		$483K Buy
7,256
+389
+6% +$25.6K 0.66% 53
2015
Q1 		$443K Sell
6,867
-1,857
-21% -$116K 0.63% 60
2014
Q4 		$515K Buy
8,724
+642
+8% +$36.2K 0.56% 64
2014
Q3 		$414K Sell
8,082
-305
-4% -$15.2K 0.48% 80
2014
Q2 		$407K Sell
8,387
-1,845
-18% -$90.9K 0.49% 82
2014
Q1 		$532K Buy
10,232
+2,263
+28% +$120K 0.55% 58
2013
Q4 		$424K Buy
+7,969
New +$406K 0.43% 101

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Banced Corp's BMY Position: Q1 2019 in Review

Banced Corp sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 10,745 shares — an estimated $559K sold.

Banced Corp first reported a position in BMY in Q4 2013 and held it in 20 quarters. The position peaked at $674K in Q1 2018. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Banced Corp reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Banced Corp sold 10,745 Bristol-Myers Squibb shares in Q1 2019, an estimated $559K.
  • Banced Corp first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 20 quarters.
  • Banced Corp's Bristol-Myers Squibb position peaked at $674K in Q1 2018.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.